-
1
-
-
77958120026
-
Alopecia areata universalis during off-label treatment with infliximab in a patient with Behçet disease
-
Beccastrini E, Squatrito D, Emmi G, Fabbri P, Emmi L. Alopecia areata universalis during off-label treatment with infliximab in a patient with Behçet disease. Dermatol Online J 2010;16: 15.
-
(2010)
Dermatol Online J
, vol.16
, pp. 15
-
-
Beccastrini, E.1
Squatrito, D.2
Emmi, G.3
Fabbri, P.4
Emmi, L.5
-
2
-
-
79952369794
-
Alopecia areata as another immune-mediated disease developed in patients treated with tumour necrosis factor blocker agents
-
Ferran M, Calvet J, Almirall M, Pujol RM, Maymo J. Alopecia areata as another immune-mediated disease developed in patients treated with tumour necrosis factor blocker agents. J Eur Acad Dermatol Venereol 2011;25: 479-84
-
(2011)
J Eur Acad Dermatol Venereol
, vol.25
, pp. 479-484
-
-
Ferran, M.1
Calvet, J.2
Almirall, M.3
Pujol, R.M.4
Maymo, J.5
-
3
-
-
4043107880
-
Alopecia areata in a patient using infliximab: New insights into the role of tumor necrosis factor on human air follicles
-
Ettefagh L, Nedorost S, Mirmirani P. Alopecia areata in a patient using infliximab: New insights into the role of tumor necrosis factor on human air follicles. Arch Dermatol 2004;140: 1012
-
(2004)
Arch Dermatol
, vol.140
, pp. 1012
-
-
Ettefagh, L.1
Nedorost, S.2
Mirmirani, P.3
-
4
-
-
33845703763
-
Alopecia areata during treatment with biologic agents
-
Tosti A, Pazzaglia M, Starace M, Bellavista S, Vincenzi C, Tonelli G. Alopecia areata during treatment with biologic agents. Arch Dermatol 2006;142: 1653-4.
-
(2006)
Arch Dermatol
, vol.142
, pp. 1653-1654
-
-
Tosti, A.1
Pazzaglia, M.2
Starace, M.3
Bellavista, S.4
Vincenzi, C.5
Tonelli, G.6
-
5
-
-
38549118358
-
Worsening of alopecia areata and de novo occurrence of multiple halo nevi in a patient receiving infliximab
-
Fabre C, Dereure O. Worsening of alopecia areata and de novo occurrence of multiple halo nevi in a patient receiving infliximab. Dermatology 2008;216: 185-6.
-
(2008)
Dermatology
, vol.216
, pp. 185-186
-
-
Fabre, C.1
Dereure, O.2
-
6
-
-
72949116745
-
Development of alopecia areata alter biological therapy with TNF-alpha blockers: Description of a case and review of the literature
-
Hernández MV, Nogués S, Ruiz-Esquide V, Alsina M, Cañete JD, Sanmartí R. Development of alopecia areata alter biological therapy with TNF-alpha blockers: Description of a case and review of the literature. Clin Exp Rheumatol 2009;27: 892-3.
-
(2009)
Clin Exp Rheumatol
, vol.27
, pp. 892-893
-
-
Hernández, M.V.1
Nogués, S.2
Ruiz-Esquide, V.3
Alsina, M.4
Cañete, J.D.5
Sanmartí, R.6
-
7
-
-
72549113014
-
Psoriasiform eruption associated with alopecia areata during infliximab therapy
-
Nakagomi D, Harada K, Yagasaki A, Kawamura T, Shibagaki N, Shimada S. Psoriasiform eruption associated with alopecia areata during infliximab therapy. Clin Exp Dermatol 2009;34: 923-4.
-
(2009)
Clin Exp Dermatol
, vol.34
, pp. 923-924
-
-
Nakagomi, D.1
Harada, K.2
Yagasaki, A.3
Kawamura, T.4
Shibagaki, N.5
Shimada, S.6
-
8
-
-
84865801700
-
Alopecia areata: A possible extraintestinal manifestation of Crohn's disease
-
Ganzetti G, Campanati A, Offidani A. Alopecia areata: A possible extraintestinal manifestation of Crohn's disease. J Crohns Colitis 2012;6: 962-3.
-
(2012)
J Crohns Colitis
, vol.6
, pp. 962-963
-
-
Ganzetti, G.1
Campanati, A.2
Offidani, A.3
|